A cGMP-signaling pathway in a subset of olfactory sensory neurons by Meyer, M. R. et al.
A cGMP-signaling pathway in a subset of olfactory sensory neurons
Mike R. Meyer, Albert Angele, Elisabeth Kremmer, U. Benjamin Kaupp, and Frank Müller 
doi:10.1073/pnas.97.19.10595 
 2000;97;10595-10600 PNAS
 This information is current as of May 2007.
 & Services
Online Information
 www.pnas.org/cgi/content/full/97/19/10595
etc., can be found at: 
High-resolution figures, a citation map, links to PubMed and Google Scholar,
 References
 www.pnas.org/cgi/content/full/97/19/10595#BIBL
This article cites 49 articles, 22 of which you can access for free at: 
 www.pnas.org/cgi/content/full/97/19/10595#otherarticles
This article has been cited by other articles: 
 E-mail Alerts
. click hereat the top right corner of the article or
Receive free email alerts when new articles cite this article - sign up in the box
 Rights & Permissions
 www.pnas.org/misc/rightperm.shtml
To reproduce this article in part (figures, tables) or in entirety, see: 
 Reprints
 www.pnas.org/misc/reprints.shtml
To order reprints, see: 
 Notes:
A cGMP-signaling pathway in a subset of olfactory
sensory neurons
Mike R. Meyer*†, Albert Angele*†, Elisabeth Kremmer‡, U. Benjamin Kaupp†, and Frank Mu¨ller†§
†Institut fu¨r Biologische Informationsverarbeitung, Forschungszentrum Ju¨lich, D-52425 Ju¨lich, Germany; and ‡Institut fu¨r Molekulare Immunologie,
GSF-Forschungszentrum fu¨r Umwelt und Gesundheit, Marchioninistrasse 25, D-81377 Mu¨nchen, Germany
Edited by David L. Garbers, University of Texas Southwestern Medical Center, Dallas, TX, and approved July 10, 2000 (received for review March 27, 2000)
It is well established that signal transduction in sensory neurons of
the rat olfactory epithelium involves a cAMP-signaling pathway.
However, a small number of olfactory neurons specifically express
cGMP-signaling components, namely a guanylyl cyclase (GC-D) and
a cGMP-stimulated phosphodiesterase (PDE2). Here, we show that
this subset of olfactory neurons expressing GC-D and PDE2 does
also express the subunit of a cGMP-selective cyclic nucleotide-
gated (CNG) channel that has been previously identified in cone
photoreceptors. Further, components of the prototypical cAMP-
signaling pathway could not be detected in this subpopulation of
cells. These results imply that these neurons use an alternative
signaling pathway, with cGMP as the intracellular messenger, and
that, in these cells, the receptor current is initiated by the opening
of cGMP-gated channels.
The binding of odorants to receptors in the ciliary membraneof olfactory sensory neurons (OSNs) initiates the odorant
signal. A cAMP-signaling pathway is thought to be involved in
mammalian chemosensory transduction in most, if not all, OSNs
(Fig. 1; for review see ref. 1). This pathway consists of serpentine
odorant receptors (ref. 2; for review see ref. 3), coupled to type
III adenylyl cyclase (ACIII) (4) through a G protein (Golf) (4, 5).
The ensuing rise in cAMP concentration (6) opens cyclic
nucleotide-gated (CNG) channels and initiates a depolarizing
response of the OSN (7). The CNG channel is exquisitely
sensitive to cAMP; however, it does not discriminate well
between cAMP and cGMP [K1/2 (constant of half-maximal
activation) values of activation of 3.0 and 1.6 mM, respectively]
(7, 8). The ligand sensitivity and selectivity is accomplished by
the assembly of three different channel subunits, a3, a4, and b1b
(9, 10). In contrast, the CNG channels from rod and cone
photoreceptors both have evolved very different cAMP vs.
cGMP sensitivities, resulting in channels that are highly cGMP
selective (11, 12).
A small population of olfactory neurons that project to a group
of atypical glomeruli in the olfactory bulb, named necklace
glomeruli, expresses an olfactory-specific guanylyl cyclase
(GC-D) and a cGMP-stimulated subtype of phosphodiesterase
(PDE2) (13, 14). GC-D is a member of the family of receptor-
type guanylyl cyclases that become activated by binding of
peptide hormones to the extracellular domain (15). Although no
ligand has yet been identified for GC-D, this group of OSNs may
not respond to normal odorants but to ligands that control some
aspects of reproductive behavior (14, 16, 17).
For a cGMP-signaling pathway in this subset of OSNs, three
different scenarios can be envisioned. These neurons could also
engage a cAMP-signaling pathway involving the same or similar
signaling components as other olfactory neurons. Within this
framework, the chief function of cGMP could be in negative
feedback, by stimulating the breakdown of cAMP via the cGMP-
regulated PDE2 (Fig. 1). A conceptual problem this model
suffers from is that the CNG channels’ ligand selectivity is poor
and a rise in cGMP itself might activate the CNG channel before
cGMP becomes degraded by PDE2. Alternatively, cAMP-
signaling components could be lacking altogether, with cGMP
serving as the principal intracellular messenger that mediates the
response of this population of OSNs (Fig. 1). Finally, these
neurons could host both G protein-coupled chemoreceptors and
receptor guanylyl cyclases that feed into independent cAMP-
and cGMP-signaling pathways.
We set out to test the hypothesis that a cGMP-selective CNG
channel represents the final target of a cGMP-signaling pathway
in these OSNs. We have identified a cGMP-selective isoform of
a CNG channel a-subunit that had previously been characterized
in cone photoreceptors (a2) and that is strictly colocalized with
GC-D and PDE2 in the olfactory epithelium. Most significantly,
all components of the canonical cAMP-signaling pathway are
absent from this subset of OSNs. Our results demonstrate that
cGMP is the messenger in a subset of OSNs and that it is
anticipated that a receptor current is produced by a cGMP-
selective CNG channel after activation of GC-D by unknown
ligand(s).
Methods
Cloning of a2 cDNA. Cloning of cDNA encoding a CNG channel
a2 subunit from rat olfactory epithelium was accomplished in
several steps. First, we performed nested PCR on olfactory first
strand cDNA by using specific primers derived from the rat
‘‘CNGgust’’ channel sequence (18). Overlapping fragments were
amplified, spanning the region from I79 to D670 of the deduced
amino acid sequence. Identical fragments were amplified by
using retinal cDNA as template. Initially we failed to clone the
missing 59 end of the channel cDNA from olfactory epithelium
by the 59RACE (rapid amplification of cDNA ends)-PCR tech-
nique, but were successful using retinal cDNA. We then verified
by PCR by using specific primers derived from the 59 end of the
retinal cDNA that this sequence also exists in cDNA from the
olfactory epithelium. For the amplification of 39 regions, one
round of PCR (40 cycles) was sufficient. For the amplification of
the 59 region, nested PCR (2 3 30 or 2 3 40 cycles) was used.
PCR experiments indicate that the a2 message was more abun-
dant in the retina than in the olfactory epithelium. We obtained
two 59-fragments from rat olfactory epithelium. The sequence of
the shorter fragment was identical with the 59-end of the retinal
a2a sequence. The longer fragment contained an insertion of
114 bp (deduced amino acid sequence: S36–R73). The final
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clones, a2a and a2b, were constructed from overlapping PCR
fragments.
Antibodies Against a2 and a3 Channel Subunits. Rabbit polyclonal
antibody FPc66K was obtained after immunization with a
maltose-binding protein (MBP)-fusion protein of the C-terminal
region of the a2 subunit (amino acids K581–D670). The antibody
was purified by sequential affinity chromatography using col-
umns with either immobilized MBP or MBP-fusion proteins. The
same fusion protein was used to produce monoclonal antibody
CNC9C1. Monoclonal antibody CRO3B10 was raised against an
MBP-fusion protein of the C-terminal region of rat a3 (amino
acids Y482–E664). Immunization of C57BLy6 mice and fusion
of immune spleen cells were performed according to standard
procedures.
Electrophysiological Recordings. Rat a2a and a2b were subcloned
into pcDNAI Amp vector (Invitrogen). A Kozak sequence was
introduced before the initiating ATG codon. HEK293 cells were
transiently transfected (19). Ligand sensitivity was determined in
excised inside-out membrane patches. The bath and pipet solu-
tions contained 100 mM KCly10 mM EGTAy10 mM Hepes (pH
7.4)yKOH. For CaM experiments, patches were first superfused
(1 min) with EGTA-containing solution to remove endogenous
CaM that might have adhered to the channel protein. Subse-
quently, patches were exposed to a solution containing 50 mM
free Ca21 (0.8 mM CaCl2 and 2 mM nitrilotriacetic acid) and
cGMP and CaM as indicated.
Immunohistochemistry. Retinae and olfactory epithelia of 3-wk-
old Sprague–Dawley rats were prepared by immersion fixation in
4% paraformaldehyde in phosphate buffer for 40 min, followed
by cryoprotection. After freezing, coronal sections were cut in a
cryostat, stained according to standard immunocytochemistry
protocols (10) and were examined by using a confocal laser
scanning microscope (Leica TCS). In double-labeling experi-
ments, intensities of excitation light and filter settings were
carefully adjusted to completely suppress crosstalk between the
fluorescence detection channels.
Primary antibodies were as follows: anti-PDE2 (chicken),
1:100; FPc66K against rat a2 (rabbit), 1:4,000; CNC9C1 against
a2 (mouse), 1:50; I-055 against GC-D (rabbit), 1:3,000; anti-
ACIII (rabbit), 1:1,500; FPc21K against rat b1 (rabbit), 1:1,600;
anti-GolfyGs (rabbit), 1:1,600; and CRO3B10 against rat a3
(mouse), 1:300. Secondary antibodies (raised in donkey) were as
follows: anti-chicken DTAF, 1:50; anti-rabbit Cy3, 1:1,000; and
anti-mouse Cy5, 1:100. In some experiments, FPc66K was visu-
alized with a biotinylated secondary antibody (1:1,000) and
extravidin-horseradish peroxidase (HRP) (1:300), using diami-
nobenzidine as chromogen (10). The anti-PDE2 antibody was a
gift of J. Beavo, GC-D antiserum I-055 was a gift of D. Garbers,
FPc21K and anti-GolfyGs were gifts of H. G. Ko¨rschen and I.
Boekhoff, respectively. Anti-ACIII was from Santa Cruz Bio-
technology, f luorescence-labeled secondary antibodies from
Dianova (Hamburg, Germany), and biotinylated antibodies and
extravidin-HRP from Sigma.
Results
Cloning of a2 Subunit from OSNs. The CNG channel in chemosen-
sory cilia is composed of three different subunits, designated a3,
a4, and b1b (9, 10). We analyzed by PCR the expression in rat
olfactory epithelium of additional CNG channel subunits. In
particular, we searched for the a2 subunit, which forms highly
cGMP-selective CNG channels. This subunit was first identified
in cone photoreceptors (20–23), but alternative splicing of the a2
gene gives rise to channels that differ in their N-terminal regions
in several tissues, including testis, kidney, heart, pineal, and taste
buds (18, 20, 21, 23–25). The nucleotide sequence of the rat a2
subunit expressed in taste buds [referred to as CNGgust (18)]
was used to design primers for PCR. As template, first strand
cDNA synthesized from rat olfactory poly(A1) RNA was used.
Two a2 cDNAs that originate from alternative splicing were
constructed from PCR products (see below and Methods).
Assigning the initiating methionine to the first ATG codon in
frame with a stop codon, the shorter form (a2a, 1,975 nucleo-
tides) is predicted to encode a 632-aa protein; the longer form
(a2b, 2,089 nucleotides) a 670-aa protein (Fig. 2).
The nucleotide sequences of CNGgust and a2ayb are identical
downstream of nucleotide 219 (aa V74 to D670 of a2b), yet bear
no sequence similarity (amino acids M1 to R73) upstream of the
V74 codon. Moreover, the N-terminal region of CNGgust is
significantly shorter than that of other a2 orthologs, whereas the
longer N-terminal regions of a2ayb and all known a2 orthologs
are highly conserved. Because R73yV74 demarcate an exon-
exon boundary, we suggest that CNGgust represents a partial
clone of rat a2 whose 59 region could carry intronic sequences.
To compare which of the a2a and a2b splice forms are
expressed in rat retina and olfactory epithelium, cDNA encoding
the N-terminal region up to transmembrane segment S2 was
amplified by a set of specific primers. Amplification of olfactory
cDNA produced fragments of 483 bp and 597 bp, whereas only
the 483-bp fragment was amplified from retinal cDNA. The
larger 597-bp fragment contains a 114-bp insertion that corre-
sponds to exon 3 of a2 orthologs (Fig. 2; amino acid sequence
highlighted by gray background). Whereas the functional signif-
icance of the a2 splice variants is not known, alternative usage
of exon 3 would change a CaM-binding motif (Fig. 2B) (25, 26)
that is encoded by the 59 end of exon 4 and the 39 region of the
preceding exon (see below).
The a2 Subunit Is Expressed in a Subset of OSNs. The expression
pattern of the a2 subunit in the olfactory epithelium was
examined with the affinity-purified antiserum FPc66K (anti-a2).
Fig. 1. Two alternative hypotheses of cGMP signaling in a subset of OSNs.
(Upper) An odorant receptor (OR) activates a cAMP-signaling pathway involv-
ing a G protein (Golf), an adenylyl cyclase (ACIII), a cyclic nucleotide-gated
(CNG) channel (a3a4b1b), and a chloride channel (ClC). The cAMP is degraded
by a CaM-dependent phosphodiesterase (PDE1C2). (Lower) Components of a
cGMP-signaling pathway and putative targets of cGMP: receptor guanylyl
cyclase GC-D; cGMP-regulated PDE2; an unknown cGMP-regulated ion chan-
nel; and the known CNG channel of the cAMP-signaling pathway.
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The antiserum is directed against the C terminus of the rat a2
and will not discriminate between N-terminal splice variants. We
tested the anti-a2 serum by immunocytochemistry on vertical
sections of the rat retina (Fig. 3a). On the left, the retinal layers
are shown by differential interference contrast (DIC) optics. On
the right, strong anti-a2 immunofluorescence is observed in
cone outer segments, which are readily identified by their typical
morphology and their location at the inner segment (IS)yrod
outer segment (ROS) border. The anti-a2 serum was used under
identical conditions to localize a2 in rat olfactory epithelium. We
detected immunolabeling in a sparse population of OSNs (Fig.
3b). Typically, the cilia of the neurons were strongly labeled,
whereas dendrite and soma showed much weaker labeling, often
in a punctate fashion (Fig. 3b Left). In some experiments, only
the cilia were stained. Labeled cells were distributed throughout
the olfactory epithelium either as single isolated neurons or in
small clusters. Often, only a few cells were labeled in a coronal
section of the nasal cavity. Larger groups of a2-immunoreactive
cells were identified in the recesses of the olfactory turbinates
near the cribriform plate (Fig. 3b Right).
The a2 Subunit Is Coexpressed with GC-D and PDE2. The distribution
of a2 is much like the regional pattern of cells that are labeled
with antibodies against PDE2 and GC-D in the mouse olfactory
epithelium (14). Using double-labeling immunocytochemistry,
we tested whether a2 and PDE2 and GC-D reside in one and the
same population of OSNs. Fig. 4a shows the immunofluorescent
detection of PDE2 in rat olfactory epithelium (Left). The cilia of
two cells are labeled. In the cell on the right, most cilia can be
identified, whereas in the left cell, only few cilia become visible,
probably, because the plane of section divided the ciliary bundle.
Somata or dendrites were not labeled above background. The
middle panel shows the same section with the anti-a2 serum. In
this case, also, the soma is faintly labeled in a punctate manner.
The right panel shows the merged image of the two fluorescent
signals with colocalization of the red and green signals producing
a yellow signal. Without exception, PDE2-positive cells were also
recognized by the anti-a2 serum (roughly 50 cells).
In the rat, as in mouse olfactory epithelium (14), we found
PDE2 and GC-D being coexpressed in the same set of OSNs.
Strong PDE2 labeling is observed in the dendritic knob and cilia;
weaker immunofluorescence is found throughout the cell (Fig.
4b Left). GC-D labeling was usually found in all parts of the cell
(Middle). In the vast majority of cells tested for double labeling,
PDE2 and GC-D were coexpressed. Only a few cells could be
counted as just PDE2 or GC-D positive, exhibiting no fluores-
cence for the other protein. We suspect that these exceptions
reflect variabilities in the labeling intensity or level of expression
rather than evidence for another subpopulation of cells, lacking
either one of the two marker proteins. We confirmed the
coexpression of a2 with PDE2 and GC-D by using an indepen-
dent monoclonal antibody CNC9C1 against a2. Fig. 4c shows
GC-D immunofluorescence in two cells (Left), the detection of
a2 with the antibody CNC9C1 (Middle), and the merged images
(Right). A third monoclonal antibody 7D8 stained the same
ciliary structures (data not shown). In summary, all three
proteins are present in one and the same cell population. We
refer to these cells as PDE2yGC-Dya2 cells.
The PDE2yGC-Dya2-Positive Cells Do Not Express Components of the
cAMP-Signaling Pathway. Fig. 5a illustrates that the PDE2yGC-
Dya2-positive cells do not express Golf. Cilia, emanating from
the dendritic knobs of three cells, are PDE2 positive (Left). An
Fig. 2. Primary structure of the rat a2b channel. (A) The exon, which is
missing in the cDNA of a2a, is highlighted by gray background. The trans-
membrane segments S1–S6, the pore region, and the cyclic-nucleotide
(cNMP)-binding domain are indicated. Established intron positions (18) are
indicated (filled triangles). Open triangles indicate intron positions that were
not determined by genomic sequencing, but could be deduced because of the
intron-exon-structure of a2 orthologs (23, 25) and the existence of consensus
sites for exon-exon boundaries. (B) Comparison of the putative CaM-binding
sites of a2a and a2b. Because of alternative usage of exon 3, rat a2a and a2b
possess different putative CaM-binding sites. The position of the amino acids
is indicated on the right (for a2b). The 1–5-8–14 motif (26, 51) of the putative
CaM-binding sites is indicated (numbers at the top).
Fig. 3. Immunohistochemical localization of the a2 subunit. (a) Section
through the rat retina. (Left) Differential interference contrast; (Right) anti-a2
immunofluorescence in cone outer segments. ROS, rod outer segments; IS,
inner segments; ONL, outer nuclear layer; OPL, outer plexiform layer; INL,
inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. (b)
Coronal sections through the rat olfactory epithelium. (Left) Anti-a2 immu-
noreactivity shown by dark diaminobenzidine reaction product. Cilia of a
single cell are strongly stained; weaker staining is found throughout the cell
body. (Right) Labeled cells are preferentially found in recesses of the olfactory
turbinates close to the cribriform plate. C, ciliary layer; SC, supporting cell
layer; OSN, somata of olfactory sensory neurons. Scale bars 5 50 mm in a and
b Right; and 10 mm in b Left.
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antiserum recognizing GolfyGs stains the ciliary layer homoge-
neously (Middle). The ciliary layer was cut slightly oblique and,
therefore, appears rather broad. In the merged image, the
PDE2-positive cilia perfectly fill holes present in the red ‘‘lawn’’
of the GolfyGs-signal; i.e., red and green signals are completely
separated and no colocalization can be observed. The same holds
for PDE2 and ACIII (Fig. 5b), confirming the finding by Juilfs
et al. (14).
CNG channels in the vast majority of OSNs are composed of
a3, a4, and b1b subunits (10). We tested whether a2 is coex-
pressed with these other channel subunits. Fig. 5c shows a
double-labeling experiment using anti-a2 serum and the mono-
clonal antibody CRO3B10 directed against a3. A single, a2-
positive cell is observed (Left), whereas the ciliary layer is
uniformly labeled with the anti-a3 antibody (Middle). The layer
of supporting cells below the cilia is devoid of fluorescence. Most
somata of the OSNs show weak immunofluorescence. The
a2-positive cilia fit precisely into a hole at the edge of the ciliary
layer (arrow); no colocalization is observed (Right). Moreover,
the soma of the a2-positive cell lacks a3-immunoreactivity.
Finally, in a double-labeling experiment with the antiserum
FPc21K, which detects all known b1 splice variants in the retina
and olfactory epithelium (10), PDE2 and b1b expression do not
overlap (Fig. 5d). In our hands, the only available monoclonal
antibody 7B11 against the a4 subunit is not useful for immuno-
cytochemistry (10), and, therefore, we cannot say whether the a4
subunit is expressed in the PDE2yGC-Dya2-positive cells. In
summary, of the four signaling components we tested, known to
be involved in the cAMP-signaling pathway of most OSNs
(GolfyGs, ACIII, a3, and b1b), none could be detected in the
PDE2yGC-Dya2-positive cells.
a2 Forms a cGMP-Selective Channel. Channels formed from either
the a2a or a2b subunit were characterized electrophysiologically
by heterologous expression in HEK 293 cells. Fig. 6a shows a
family of current-voltage (IyVm) relations recorded in the inside-
out patch configuration at different cGMP concentrations.
The dose-response relations for the a2a and a2b channels at
160 mV are shown in Fig. 6b. All currents were normalized to
currents recorded at saturating cGMP concentrations. At 160
mV, the currents activated by saturating cAMP and cGMP are
identical (Fig. 6b), whereas at 260 mV, Imax,cAMPyImax,cGMP is
roughly 0.7 (data not shown). Solid lines represent fits of the Hill
equation IyImax 5 cny(cn 1 K1/2n) to the data from a2a channels,
and dashed lines from a2b channels. Mean values for the
concentration of half-maximal activation K1/2 and the Hill co-
efficient n are summarized in Table 1. The cAMP concentrations
needed to activate both channel forms were roughly two orders
of magnitude larger than for cGMP, i.e., both channel forms are
highly cGMP selective. A high cGMP selectivity is preserved
after coexpression of modulatory subunits (b1b or a4, respec-
tively; data not shown). Recently, a second b subunit has been
identified that was suggested to be expressed in cone photore-
ceptors. Coexpression with its cognate a2 subunit produces
heteromeric channels that are highly cGMP selective (27). Thus,
coexpression of the a2 subunit with all known modulatory
subunits gives rise to cGMP-selective channels.
Fig. 4. The a2 subunit is coexpressed with PDE2 and GC-D. (a Left)
Immunofluorescent detection of PDE2 in cilia of two cells; (Middle) anti-a2
immunofluorescence (antibody FPc66K); (Right) merged image showing
colocalization of PDE2 and a2. (b Left) anti-PDE2 immunofluorescence; (Mid-
dle) anti-GC-D immunofluorescence; (Right) merged image; both proteins are
colocalized. (c Left) anti-GC-D immunofluorescence; (Middle) anti-a2 immu-
nofluorescence (antibody CNC9C1); (Right) merged image; both proteins are
colocalized. Scale bars 5 10 mm. Fig. 5. Components of the olfactory cAMP-signaling pathway are absent
from a2-positive neurons. (a Left) Cilia of three PDE2-positive cells; plane of
section is slightly oblique. (Middle) GolfyGs-positive cilia form a continuous
layer; arrow indicates the position of one PDE2-positive ciliary bundle in the
red ‘‘lawn.’’ (Right) Merged image, no colocalization is observed. (b Left) Cilia
of a PDE2-positive cell; (Middle) ACIII-positive cilia form a continuous layer
with a hole (arrow); (Right) merged image; no colocalization. (c Left) Anti-a2
immunofluorescence. (Middle) a3-positive cilia; note the hole (arrow). (Right)
Merged image, no colocalization. (d Left) PDE2-positive cilia. (Middle) b1 is
found throughout the ciliary layer; arrow indicates the position of a PDE2-
positive ciliary bundle. (Right) Merged image, no colocalization. Scale bars 5
10 mm.
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a2 Channels Are Modulated by CaM. The N-terminal region of the
a2 subunit carries a putative CaM-binding site similar to that
identified in the a3 subunit (25, 28). We assayed whether the
channels composed of either splice variant are modulated by
binding of CaM. Fig. 6c shows an experiment with the a2b splice
form. On excision, the patch was superfused with a solution
containing 10 mM EGTA to remove endogenous CaM that
might adhere to the channel. The current was then recorded
continuously (in solutions containing 50 mM free Ca21 and the
indicated concentrations of cGMP; or cGMP and CaM) as Vm
was switched from 240mV to 40 mV in 1-s intervals. At the
beginning, the patch was superfused with 100 mM cGMP to
determine saturating currents. In cGMP-free solutions, only
small leak currents were measured. During superfusion for
roughly 1 min with 3 mM cGMP (a concentration close to the K1/2
value), the cGMP-activated current was constant. When the
solution was changed to 3 mM cGMP plus 1 mM CaM, the
current declined within 30 s to approximately 50% of its previous
value. Saturating currents at the beginning and the end of the
experiment were identical, and the CaM effect was fully revers-
ible when the patch was superfused for 1 min with 10 mM EGTA
(data not shown). Similar results were obtained in six experi-
ments. The CaM effect was similar on the two splice variants, a2a
and a2b.
Discussion
Ever since the discovery of the first signaling molecules in
olfactory neurons, two rival signaling pathways have been in-
voked. One hypothesis assumes that all OSNs use cAMP for
odorant signaling; the opponent hypothesis states that two
independent signaling pathways exist that use either cAMP or
IP3 (29). Another intracellular messenger, cGMP, was consid-
ered as an ‘‘adaptive’’ molecule that modulates the cAMP
pathway by ill-defined mechanisms (30–32). The report by Juilfs
et al. (14) and our own results collectively support the notion that
some OSNs employ a cGMP pathway for odorant signaling. We
show that the cGMP-selective a2 channel is expressed in the
same OSNs that express GC-D and PDE2. Furthermore, we and
Juilfs et al. (14) demonstrate that Golf, ACIII, PDE1C2, and the
CNG channel subunits a3 and b1b—characteristic markers for
the enzymatic make-up of the prototypical OSNs—are absent
from PDE2yGC-Dya2 cells. These findings rule out the coex-
istence of the known cAMP- and this novel cGMP-signaling
pathway. However, we cannot exclude that this subset of OSNs
employs other cAMP-signaling components. Indirect support for
these conclusions comes from mice with a targeted deletion of
the a3 subunit (33). The ‘‘necklace’’ glomeruli in the olfactory
bulb are spared from the morphological alterations observed in
the typical glomeruli of the null-mice, suggesting that the
atypical glomeruli receive innervation from a subset of receptor
neurons that use a pathway independent of cAMP signaling.
A precedent for chemosensory signaling using a cGMP-
pathway exists in Caenorhabditis elegans, where at least 29
different receptor GCs have been identified (34). Several of
these receptors have been localized to sensory neurons that also
express the CNG channel genes tax-2 and tax-4 (35, 36), which
produce highly cGMP-selective channels. Thus, it appears that a
phylogenetically ancient chemosensory system that is distinct
from the system processing volatile odors conveys sensory
information by way of a cGMP-, rather than a cAMP-, signaling
pathway. Both pathways are endowed with entirely different
components and probably evolved independently of each other.
It will be a formidable task for future work to unravel the
biological function(s) of this unique chemosensory system and to
identify the respective physiological ligands.
CNG channels are nonselective cation channels that support
inward currents carried by Na1 and Ca21 ions (for review see ref.
Fig. 6. Properties of heterologously expressed a2 channels. (a) Current-voltage (IyVm) relations of a2a channels in the presence of different cGMP
concentrations. (b) Dose-response curves for a2a (solid lines) and a2b (dashed lines) at Vm 5 160 mV. All currents were normalized to currents at saturating cGMP.
For clarity, data points and error bars were omitted from dashed traces. (c) a2 channels are modulated by CaM. Vm was switched from 240 mV to 140 mV in
1-s intervals. The inside-out patch (a2b) was superfused with 100 mM cGMP to record saturating currents, followed by superfusion in 0 mM cGMP. During
superfusion with 3 mM cGMP for 1 min, the current stayed constant. With 3 mM cGMP and 1 mM CaM, the current decreased by roughly 50% within 30 s. The
current at saturating cGMP (100 mM) was not altered by CaM.
Table 1. Activation parameters of a2 channels
Vm 5 260 mV Vm 5 160 mV
Rat a2a Rat a2b Rat a2a Rat a2b
K1⁄2 (cGMP)ymM (6) 3.7 6 1.0 4.0 6 1.4 2.0 6 0.4 1.7 6 0.7
n (cGMP) (6) 1.8 6 0.2 1.7 6 0.3 2.0 6 0.3 2.0 6 0.3
K1⁄2 (cAMP)ymM (6) 441.0 6 94.0 613.0 6 83.0 277.0 6 67.0 396.0 6 85.0
n (cAMP) (6) 1.6 6 0.2 1.5 6 0.2 1.5 6 0.1 1.5 6 0.1
IcAMPyIcGMP (12) 0.7 6 0.1 0.7 6 0.1 1.0 6 0.1 1.0 6 0.1
Mean 6 SD of K1⁄2 values and Hill coefficients n. The number of experiments is indicated in parentheses.
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11). In OSNs that use a cAMP-signaling pathway, the odorant-
stimulated rise in [Ca21]i (37) plays an important role in both
excitation and adaptation. A rise in [Ca21]i activates Cl2 chan-
nels that carry a large fraction of the odorant-induced receptor
current (38–40). Ca21 also stimulates cAMP hydrolysis by the
ciliary CaM-dependent PDE1C2 (14, 41), and it attenuates the
cAMP sensitivity of the CNG channel by a mechanism involving
CaM (28, 42). Both mechanisms terminate the odorant response
and lower the sensitivity of the OSN to subsequent stimulation
(43). CNG channels containing a2 subunits are roughly as Ca21
permeable as the a3a4b1b channels (44–47), and stimulation of
OSNs equipped with a cGMP-signaling pathway is expected to
raise [Ca21]i.
At present, we can only speculate about a Ca21-dependent
feedback in PDE2yGC-Dya2 cells. The CaM-dependent
PDE1C2 is absent from these cells (14), and the CaM action on
a2 channels is much weaker than on CNG channels in typical
OSNs (42). It is conceivable that adaptation to ligands that
control important aspects of behavior differs from the fast and
complete adaptation to normal odors in typical OSNs. Alterna-
tively, an unknown Ca21-binding protein with much higher
efficacy than CaM might be the authentic modulator of CNG
channels in PDE2yGC-Dya2 cells.
By analogy to what is known in photoreceptors, the shift of the
cGMP sensitivity may not be the only action of Ca21 inside
PDE2yGC-Dya2 cells. Guanylyl cyclases GC-E and GC-F ex-
pressed in retinal photoreceptors are regulated by [Ca21]i (48) and
not by extracellular ligands. Their Ca21 sensitivity is mediated by a
set of guanylyl cyclase-activating proteins (GCAPs), which are
members of the large family of Ca21-binding proteins (for review
see ref. 49). GC-D is phylogenetically more akin to the Ca21-
regulated GC-E and GC-F than to receptor GCs-AyByC, which are
activated by peptide ligands. In particular, GC-D and GC-EyF
share characteristic sequence similarity in a regulatory domain that
is involved in binding of GCAPs (50). This similarity raises the
intriguing possibility that GC-D activity is under the dual control of
an unknown extracellular ligand and [Ca21]i.
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